Omega Healthcare Investors, Inc.
OHI · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.46 | 0.55 | -1.45 | -4.92 |
| FCF Yield | 1.92% | 2.24% | 1.69% | 2.21% |
| EV / EBITDA | 204.03 | 53.24 | 60.21 | 58.35 |
| Quality | ||||
| ROIC | 10.40% | 1.72% | 1.55% | 1.65% |
| Gross Margin | 98.88% | 98.85% | 98.80% | 98.77% |
| Cash Conversion Ratio | 13.47 | 1.71 | 1.91 | 2.00 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.38% | 9.34% | 8.60% | 6.18% |
| Free Cash Flow Growth | 0.09% | 31.50% | -20.53% | 23.84% |
| Safety | ||||
| Net Debt / EBITDA | 51.93 | 15.20 | 16.53 | 17.23 |
| Interest Coverage | 0.00 | 3.42 | 3.02 | 3.21 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 80.43 | 643.16 | 654.52 | 654.72 |